Posted on: April 15, 2021 Posted by: Betty Lee Comments: 0


Denmark is the primary nation within the EU to drop the AstraZeneca coronavirus vaccine from its COVID-19 inoculation program, amid issues over its severe uncomfortable side effects. The choice was made following stories of uncommon blood clots in some recipients. The Danish well being authority mentioned the hyperlink is “uncommon however severe”.

Denmark is a rustic of 5.8 million folks and has reported 238,869 coronavirus circumstances to date.

Of these circumstances, 2,446 folks died and to date, 883,375 folks have been vaccinated in opposition to the virus.

General, 77 p.c of these vaccinated acquired the Pfizer/BioNTech vaccine, 7.8 p.c Moderna and 15.3 p.c the Oxford/AstraZeneca vaccine.

Denmark first suspended the usage of the AstraZeneca jab on March 11 and has now determined to “proceed the rollout of its vaccination programme, with out AstraZeneca”.

The nation initially paused the usage of the vaccine for 3 weeks to March 25, with lower than 150,000 folks in Denmark receiving the AstraZeneca vaccine.

The Danish Well being Authority has scheduled a briefing in regards to the AstraZeneca for Thursday at 2pm, with sources indicating the nation will completely withdraw the AstraZeneca vaccine from the nation’s Covid vaccination programme.

As an alternative, the nation is providing its residents the Pfizer, Moderna and Johnson & Johnson vaccines.

READ MORE: Biden calls for showdown with Putin after fierce cellphone name

Requested whether or not the AstraZeneca vaccine was protected, Dr Martin Michaelis, from the College of Kent, instructed Categorical.co.uk: “This depends upon what you imply by protected. In the event you imply that there can’t be any danger related to a drug or a vaccine, that is an unrealistic expectation.

“All medication and vaccines have some uncomfortable side effects. An overdose of paracetamol might be lethal.

“Hundreds of people die from aspirin. The usage of oral contraceptives (the ‘Tablet’) is related to an enhanced danger of blood clots (thrombosis).

“Therefore, the query is whether or not the advantage of a remedy outweighs the dangers or not.”

He added: “Typically, the Oxford/AstraZeneca vaccine may be very protected. It has been examined in tens of 1000’s of people in medical trials and given to tens of millions of sufferers.

“Just lately, issues have been raised a few connection between a sure type of blood clotting (thrombosis) within the mind, which known as cerebral venous sinus thrombosis.

“This can be a very uncommon situation, however it isn’t precisely clear how uncommon. Estimations are sometimes within the vary of three to 4 circumstances per million people per yr.

“Nevertheless, different research have steered that this can be an underestimation and that about 15 circumstances per million people per yr are extra real looking.”

DON’T MISS
VDL takes revenge on AstraZeneca: EU chief shuns agency for Pfizer [INSIGHT]
EU ‘to END vaccine AstraZeneca and Johnson & Johnson partnership’ [EXPLAINER]
Johnson & Johnson’s blunt ultimatum to EU earlier than rollout delay [ANALYSIS]

The virologist mentioned Germany had seen the best variety of circumstances of any nation to date.

He instructed Categorical.co.uk: “Germany has reported 31 circumstances of cerebral venous sinus thrombosis in 2.7 million people, who had been vaccinated with the Oxford/AstraZeneca vaccine, whereas 22 circumstances have been recorded amongst 18.1 million people within the UK.

“A distinction between Germany and the UK is that the Oxford/AstraZeneca vaccine was initially used predominantly for youthful people in Germany.”

Professor Michaelis added: “Given the obtainable proof, it’s unimaginable to resolve whether or not the Oxford/AstraZeneca vaccine is answerable for the noticed circumstances of cerebral venous sinus thrombosis or whether or not that is only a coincidence.

“On this context, it additionally must be appreciated that when you begin to carefully monitor a cohort of individuals you will notice modifications within the incidence of many occasions purely by likelihood.

“If you wish to present a causative hyperlink, you’ll both want a really robust and constant correlation and an understanding of the underlying mechanisms that you would be able to then take a look at.

“So far as I can see, it’s nonetheless too early to say whether or not circumstances of cerebral venous sinus thrombosis are literally elevated after vaccinations with the Oxford/AstraZeneca vaccine.”

Which international locations have restricted the usage of AstraZeneca to date and should completely ban its use?

France, Germany and the Netherlands all restricted the usage of the vaccine to older folks, over fears youthful persons are extra vulnerable to blood clots within the wake of the EMA announcement.

France suggested well being officers that folks aged underneath 55 would obtain an alternative choice to AstraZeneca for his or her second shot earlier this month.

Vaccine advisers within the US have instructed CNN they don’t foresee AstraZeneca’s vaccine getting used within the nation.

Germany suspended the usage of the AstraZeneca vaccine for these under the age of 60 on the finish of final month.

Canada has additionally restricted the usage of the vaccine to these aged over 55.

Italian well being officers mentioned the AstraZeneca vaccine ought to solely be given to these aged 60 and above.

The Sicilian president Nello Musumeci mentioned as much as 80 p.c of these provided the AstraZeneca vaccine had refused it.





Supply hyperlink

Leave a Comment